Jieyu Zou

Jieyu Zou - Profile and Investment Details

Find investors who align with your industry, stage, and vision. Unlock Jieyu Zou’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.

Get connected with all investors today
Investor type
Country
City/Area
Stages

-

Contacts
fir***@***.comLinkedin Available after registration.
Markets
Past investments
KSQ TherapeuticsxInnovent BiologicsAbbisko TherapeuticsMicrotech MedicalMetacrineImmuneOnco BiopharmaTargeting OneAlectorHangzhou Just Biotherapeutics (Just China)Fortis TherapeuticsHarpoon TherapeuticsLegend BiotechElpiscience BiopharmaceuticalsAnsun BioPharmaGeneseeqTurning Point TherapeuticsReadCoordMedSinglera GenomicsSingleron BiotechnologiesIMPACT TherapeuticsNucleixRiboX TherapeuticsGeneceptionNuVera MedicalCARsgen TherapeuticsJust - Evotec BiologicsTerns PharmaceuticalsTmunity Therapeutics360 HealthLilly Asia Ventures 礼来亚洲基金TranscentaNextCureNuohui HealthRegor TherapeuticsVIRTUE DXInventisBioEdiGeneTempest TherapeuticsGracell BiotechnologiesSonoma BioTherapeuticsPeptistarNiKang TherapeuticsInhibrxRongchang PharmaceuticalRemegenMailing YiliaoMagnolia NeuroSciencesBurning Rock BiotechPassage BioFountain Medical DevelopmentCanSinoBIOMabSpace BiosciencesSansure BiotechNovoCodexGritstone OncologyVeritas GeneticsACEA BIOPeijia MedicalInsilico MedicineSynerK, IncJacobio PharmaceuticalsAvedro360 HaoyaoDizal PharmaConnect BiopharmaceuticalsQihan BiotechChimagen BiosciencesIonova Life Science
Investor Profile

Jieyu Zou is a Venture Capital based in Shanghai, China with a diverse investment portfolio that includes companies such as KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical, Metacrine, ImmuneOnco Biopharma, Targeting One, Alector, Hangzhou Just Biotherapeutics (Just China), Fortis Therapeutics, Harpoon Therapeutics, Legend Biotech, Elpiscience Biopharmaceuticals, Ansun BioPharmaGeneseeq, Turning Point Therapeutics, ReadCoor, dMed, Singlera Genomics, Singleron Biotechnologies, IMPACT Therapeutics, Nucleix, RiboX Therapeutics, Geneception, NuVera Medical, CARsgen Therapeutics, Just - Evotec Biologics, Terns Pharmaceuticals, Tmunity Therapeutics, 360 Health, Lilly Asia Ventures 礼来亚洲基金, Transcenta, NextCure, Nuohui Health, Regor Therapeutics, VIRTUE DX, InventisBio, EdiGene, Tempest Therapeutics, Gracell Biotechnologies, Sonoma BioTherapeutics, Peptistar, NiKang Therapeutics, Inhibrx, Rongchang Pharmaceutical, Remegen, Mailing Yiliao, Magnolia NeuroSciences, Burning Rock Biotech, Passage Bio, Fountain Medical Development, CanSinoBIO, MabSpace Biosciences, Sansure Biotech, NovoCodex, Gritstone Oncology, Veritas Genetics, ACEA BIO, Peijia Medical, Insilico Medicine, SynerK, Inc, Jacobio Pharmaceuticals, Avedro, 360 Haoyao, Dizal Pharma, Connect Biopharmaceuticals, Qihan Biotech, Chimagen Biosciences, Ionova Life Science, . Over time, Jieyu Zou has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Jieyu Zou is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Drug Discovery, Genetics, Wellness, Women Founded, Investment Management, Life Science, Engineering, Robotics, Information Technology (IT), Venture Fundraising, Software, Manufacturing, Biotechnology, Genomics, Clinical Trials, Research, Reviews and Recommendations, Health Diagnostics, Medical, B2B, Therapeutics, Media and Entertainment, Personal Health, Pharmaceuticals, Healthcare Technology, Oncology may find it worthwhile to explore potential connections with Jieyu Zou, as their portfolio suggests a familiarity and interest in this area.

Understanding Jieyu Zou’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.

Finally raise your round with Angel Match

Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.

Find the perfect investors today